David Milligan

Equibles does not estimate personal net worth.

About David Milligan

Earlier roles on record: Board Member at Madrigal Pharmaceuticals, Inc. (MDGL) until June 15, 2023. Madrigal Pharmaceuticals, Inc. reported in an 8-K filed June 20, 2023 that David Milligan resigned as Class III director on the Board of Directors, effective June 15, 2023.

“On June 15, 2023, Keith R. Gollust and David Milligan, Ph.D., each Class III directors on the Board of Directors (the "Board") of Madrigal Pharmaceuticals, Inc. (the "Company"), resigned from the Board, effective immediately.”

Madrigal Pharmaceuticals, Inc. Form 8-K, filed June 20, 2023 · Read the filing

Affiliation history

Madrigal Pharmaceuticals, Inc. (MDGL)
Board Member

Proxy statement

Start not stated–2023-06-15

Company network

Madrigal Pharmaceuticals, Inc.

MDGL

Biotechnology · Healthcare

Board Member

Recent activity

Executive change Resigned: Class III director on the Board of Directors Madrigal Pharmaceuticals, Inc. (MDGL)
2023-06-15